BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32056686)

  • 1. Estimates of relative beta radiation doses on central and lateral axes of ruthenium/rhodium COB-type plaque used in eye brachytherapy.
    De Paiva E
    Appl Radiat Isot; 2020 Feb; 156():108991. PubMed ID: 32056686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Monte Carlo dose calculation system for ophthalmic brachytherapy based on a realistic eye model.
    Miras Del Río H; Ortiz Lora A; Bertolet Reina A; Terrón León JA
    Med Phys; 2021 Aug; 48(8):4542-4559. PubMed ID: 34250607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calculation of dose distributions for 12 106Ru/106Rh ophthalmic applicator models with the PENELOPE Monte Carlo code.
    Hermida-López M
    Med Phys; 2013 Oct; 40(10):101705. PubMed ID: 24089895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data on estimations of relative dose rates along central axis of symmetric and asymmetric
    Paiva E
    Data Brief; 2021 Feb; 34():106620. PubMed ID: 33365366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of gold nanoparticle effects in brachytherapy by an electron emitter ophthalmic plaque.
    Hashemi S; Aghamiri MR; Kahani M; Jaberi R
    Int J Nanomedicine; 2019; 14():4157-4165. PubMed ID: 31239674
    [No Abstract]   [Full Text] [Related]  

  • 6. Dose characteristics of Au-198 eye brachytherapy applicator: A Monte Carlo study.
    Kamrani S; Aghamiri SMR; Hashemi S
    Appl Radiat Isot; 2021 Oct; 176():109866. PubMed ID: 34293507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between beta radiation dose distribution due to LDR and HDR ocular brachytherapy applicators using GATE Monte Carlo platform.
    Mostafa L; Rachid K; Ahmed SM
    Phys Med; 2016 Aug; 32(8):1007-18. PubMed ID: 27499370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorbed dose distributions from ophthalmic
    Hermida-López M; Brualla L
    Med Phys; 2018 Apr; 45(4):1699-1707. PubMed ID: 29399810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monte Carlo simulation of COMS ophthalmic applicators loaded with Bebig I25.S16 seeds and comparison with planning system predictions.
    Miras H; Terrón JA; Lallena AM
    Phys Med; 2013 Nov; 29(6):670-6. PubMed ID: 22858007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface dose rate variations in planar and curved geometries of
    Bakshi AK; Shrivastava V; Chattaraj A; Samuel K; Palani Selvam T; Sapra BK; Sinharoy P; Banerjee D; Sugilala G; Manohar S; Kaushik CP
    Phys Med; 2021 Sep; 89():200-209. PubMed ID: 34399207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.
    Lesperance M; Martinov M; Thomson RM
    Med Phys; 2014 Mar; 41(3):031706. PubMed ID: 24593710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monte Carlo dosimetry of the eye plaque design used at the St. Erik Eye Hospital for (125)I brachytherapy.
    Karlsson M; Nilsson J; Lundell M; Carlsson Tedgren A
    Brachytherapy; 2014; 13(6):651-6. PubMed ID: 24950821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen nanobubbles: A novel approach toward radio-sensitization agents.
    Hashemi S; Aghamiri SM; Siavashpour Z; Kahani M; Zaidi H; Jaberi R
    Med Phys; 2023 Oct; 50(10):6589-6599. PubMed ID: 37278345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced Collapsed cone Engine dose calculations in tissue media for COMS eye plaques loaded with I-125 seeds.
    Morrison H; Menon G; Larocque MP; van Veelen B; Niatsetski Y; Weis E; Sloboda RS
    Med Phys; 2018 Jul; 45(7):3349-3360. PubMed ID: 29729009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetry of ruthenium-106 ophthalmic applicators with thin layer thermoluminescence dosimeters - Clinical quality control.
    Krause F; Möller M; Risske F; Siebert FA
    Z Med Phys; 2020 May; 30(2):142-147. PubMed ID: 31818650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model-based dose calculations for COMS eye plaque brachytherapy using an anatomically realistic eye phantom.
    Lesperance M; Inglis-Whalen M; Thomson RM
    Med Phys; 2014 Feb; 41(2):021717. PubMed ID: 24506608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidimensional dosimetry of ¹⁰⁶Ru eye plaques using EBT3 films and its impact on treatment planning.
    Heilemann G; Nesvacil N; Blaickner M; Kostiukhina N; Georg D
    Med Phys; 2015 Oct; 42(10):5798-808. PubMed ID: 26429254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric study of the 15 mm ROPES eye plaque.
    Granero D; Pérez-Calatayud J; Ballester F; Casal E; de Frutos JM
    Med Phys; 2004 Dec; 31(12):3330-6. PubMed ID: 15651616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A patch source model for treatment planning of ruthenium ophthalmic applicators.
    Astrahan MA
    Med Phys; 2003 Jun; 30(6):1219-28. PubMed ID: 12852546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COMS eye plaque brachytherapy dosimetric sensitivity to source photon energy and seed design.
    Gagne NL; Rivard MJ
    Appl Radiat Isot; 2013 Sep; 79():62-6. PubMed ID: 23728350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.